MedPath
NMPA Approval

Ipratropium Bromide Solution for Inhalation

国药准字H20244847

September 10, 2024

Drug Information

吸入用异丙托溴铵溶液

吸入制剂

2ml:0.5mg(按C₂₀H₃₀BrNO₃计)

化学药品

September 10, 2024

Company Information

Applicant Company

太仓港港口开发区石化区协鑫西路12号

Manufacturing Company

江苏太仓港港口开发区石化区协鑫西路12号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用异丙托溴铵溶液 - NMPA 批准文号 | MedPath